ScholarIQanswers from OpenAlex

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years

PaperCitations, authors & open-access status

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years have?

ScholarIQcitation count

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years has 70 citations in the OpenAlex counts ScholarIQ stores.

When was Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years published?

ScholarIQyear

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years has 2017 year in the ScholarIQ index.

What is the open-access status of Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years?

ScholarIQoa status

Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years has gold oa status in the ScholarIQ index.

What is the DOI of Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years?

ScholarIQdoi

The DOI for Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years is on the source record.

What is the PMID of Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years?

ScholarIQpmid

The PMID for Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years is on the source record.

What is the OpenAlex record for Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years?

ScholarIQopenalex

The OpenAlex for Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial